Právní předpis byl sestaven k datu 14.07.2026.
Zobrazené znění právního předpisu je účinné od 24.11.2011.
Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2012
325/2011 Sb.
325
XXXXXXX
Xxxxxxxxxxxx xxxxxxxxxxxxx
xx xxx 1. xxxxxxxxx 2011
x antigenním xxxxxxx xxxxxxxxxx xxxxx xxx pravidelná, zvláštní x xxxxxxxxx xxxxxxxx xxx xxx 2012
Xxxxxxxxxxxx xxxxxxxxxxxxx xxxxx §80 xxxx. 1 xxxx. x) xxxxxx x. 258/2000 Xx., x xxxxxxx xxxxxxxxx xxxxxx x x xxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxx, xx xxxxx zákona x. 298/2011 Xx., stanoví xx xxxxxxx doporučení Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx složení očkovacích xxxxx xxx xxxxxxxxxx, xxxxxxxx x mimořádná xxxxxxxx xxx xxx 2012:
1. Xxxxxxxxx xxxxxxx očkovacích látek xxx pravidelná očkování
1x) xxxxxxxxxxx xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx hepatitidě X, nákazám xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx typ x (XXxXXxxXXXXXX):
Xxxxxxxxx xxxxxxxxxx
Pertussis xxxxxxxxxxxxxx xxxxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxx proteinum
Xxxxxxxxxxx xxxxxxxxxx
Xxxxxx anatoxinum xxx.
Xxxxxxxxx tegiminis xxxxxxxxxxx X xxxxxxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1
Virus xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3
Xxxxxxxxxx Xxx: Xxxxxxxxxxxxxxxxxxx xxxxxxxx Xxxxxxxxxxx xxxxxxxxxx x, Xxxxxx anatoxinum
1x) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx (XXxX):
Diphtheriae xxxxxxxxxx ≥ 30 xxxxxxxxxxxxx xxxxxxxx
Tetani xxxxxxxxxx ≥ 40 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx (XX) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (FHA) 25 xxxxxxxxxx
Xxxxxxxxxxx (69kD) 8 mikrogramů
1x) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxxx vyvolaným Xxxxxxxxx xxxxxxxxxx x (XXxXXxx):
Xxxxxxxxxxx anatoxinum | xxx. 30 mezinárodních xxxxxxxx |
Xxxxxx anatoxinum | xxx. 40 xxxxxxxxxxxxx xxxxxxxx |
Xxxxxxxxx anatoxinum (XX) | 25 xxxxxxxxxx |
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx | (XXX) 25 xxxxxxxxxx |
Pertactinum (69xX) | 8 mikrogramů |
Xxxxxxxxxxx xxxxxxxxxx X | 10 mikrogramů |
cum xxxxxxxxx xxxxxxxx | 20-40 xxxxxxxxxx |
1x) xxxxxxxx xxxxx proti xxxxxxx x tetanu - xxxxxxxxx:
Xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxx .................. min. 30 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxxx xxxxxx purificatum ........................... xxx. 40 xxxxxxxxxxxxx xxxxxxxx
1x) xxxxxxxx látka proti xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx b:
1 xxxxx xxxxxxxxxxxxx xxxxxxx xxxxxxxx: Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) cum Xxxxxxxxx xxxxxxxx (30 xxxxxxxxxx).
1x) xxxxxxxx xxxxx xxxxx tetanu:
Xxxxxx xxxxxxxxxx ............................................. xxx. 40 xxxxxxxxxxxxx jednotek
1x) xxxxxxxx látka xxxxx xxxxxx xxxxxxxxxx X x xxxxxx xxxxxxx:
Antigenum tegiminis xxxxxxxxxxx B
1x) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx X x xxxxxxx xxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X
1xx) očkovací xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x zarděnkám:
Xxxxxxxxxxx virus xxxxxxxxxx (Xxxxxxx) min. 103,0 xxxxxxxx dávka pro xxxxxxxx xxxxxxx50 Xxxxxxxxxxx xxxxx attenuatum (XXX 4385) min. 103,7 xxxxxxxx dávka xxx xxxxxxxx xxxxxxx50 Xxxxxxxx xxxxx attenuatum (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx xxxxx xxx buněčnou xxxxxxx50
1x) xxxxxxxx xxxxx xxxxx dětské přenosné xxxxx x inaktivované xxxxx:
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Xxxxxxx) ..... 40 xxxxxxxxxxx X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2 (XXX-1) .......... 8 xxxxxxxxxxx X xxxxxxxx*
Virus xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3 (Xxxxxxx) ...... 32 xxxxxxxxxxx X xxxxxxxx*
* xxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxx xxxxxxxxx pomocí xxxxxx xxxxxxxxxxxxx xxxxxx.
1j) xxxxxxxx látka xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx v xxxxxxxxxxxxxxx xxxxxxx:
Polysaccharidum Xxxxxxxxxxxx xxxxxxxxxx xxxxx:
1, 2, 3, 4, 5, 6B, 7F, 8, 9X, 9X, 1XX, 11 X, 12X, 14, 15X, 17X,
18X, 19X, 19X, 20, 22X, 23X, 33X ................ 25 xxxxxxxxxx x xxxxxxx xxxxxxxx
1k) xxxxxxxx látka konjugovaná xxxxx xxxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 1
Pneumococcale polysaccharidum xxxxxxxxx 3
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 4
Xxxxxxxxxxxxx polysaccharidum sérotypus 5
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6A
Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 6B
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 7X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9V
Pneumococcale xxxxxxxxxxxxxxx sérotypus 14
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 18X
Pneumococcale polysaccharidum xxxxxxxxx 19X
Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X
1xx) xxxxxxxx xxxxx proti záškrtu, xxxxxxxx kašli (acelulární xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
Diphtheriae anatoxinum xx xxxx xxx 2 xxxxxxxxxxx xxxxxxxx
Xxxxxx xxxxxxxxxx ne xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx
Pertusové xxxxxxxx:
Pertussis xxxxxxxxxx .......... 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx filamentosum 8 xxxxxxxxxx
Xxxxxxxxx .................... 2,5 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:
xxxxx 1 (xxxx Xxxxxxx) .... 40 X xxxxxxxx xxxxxxxx
xxxxx 2 (kmen XXX-1) ......... 8 X jednotek xxxxxxxx
xxxxx 3 (kmen Xxxxxxx) ...... 32 X jednotek antigenu
XXXX
1xx) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx xxxxx (acelulární xxxxx), tetanu, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxxxxxxx xxxxxx | xxxx nebo xxxxx 2 mezinárodní xxxxxxxx (2 Xx) | ||
Xxxxxxxxx xxxxxx | xxxx xxxx xxxxx 20 mezinárodních xxxxxxxx (5 Xx) | ||
Xxxxxxxxx antigeny: | |||
Xxxxxxxxx toxoid | 2,5 mikrogramu | ||
Xxxxxxxxxxxx xxxxxxxxxxxx | 5 xxxxxxxxxx | ||
Fimbrie xxxx 2+3 | 5 xxxxxxxxxx | ||
Pertaktin | 3 xxxxxxxxxx | ||
Xxxxx xxxxxxxxxxxxx xxxx 1 (xxxxxxxxxxxx) | 40 antigenních X xxxxxxxx | ||
Xxxxx xxxxxxxxxxxxx xxxx 2 (xxxxxxxxxxxx) | 8 xxxxxxxxxxx X xxxxxxxx | ||
Xxxxx xxxxxxxxxxxxx xxxx 3 (xxxxxxxxxxxx) | 32 antigenních X xxxxxxxx | ||
1x) xxxxxxxx xxxxx xxxxx xxxxxxxxxxx:
Xxxxxxxx Calmette Xxxxxx (atenuované) 100&xxxx;000 - 300 000 X.X.* (xxxx Copenhagen 1331)
*X.X. = živé xxxxxxx
1x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx B xxx xxxxx zařazené xx xxxxxxxxxxxx xxxxxxxx:
Antigenum xxxxxxxxx xxxxxxxxxxx X xxxxxxxxxxxxxx 20 mikrogramů; xxxxxxxx AS04C xxxxxxxxxx 3-X-xxxxxx-4-xxxxxxxxxxxx-xxxxx X (XXX) 50 xxxxxxxxxx v 1 xxxxx
2. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxx xxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B
2x) xxxxxxxx xxxxx proti xxxxxxxxx
Xxxxx xxxxxx xxxxxxxxxxx (xxxx Xxxxxx xxxxxx PM/WI 38&xxxx;1503-3X xxxx xxxx rovno 2,5 xxxxxxxxxxxxx xxxxxxxx x 1 xxxxx (0,5 xx)
3. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxx
3x) očkovací xxxxx xxxxx virové xxxxxxxxxx X ve xxxxxxx pro dospělé:
Hepatitis X xxxxx inactivatum
3b) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě A xx xxxxxxx xxx xxxx:
Xxxxx xxxxxxxxx X inactivatum
Xxxxxxx:
xxx. XXXx. Xxxxx, XXx., x. x.
Informace
Xxxxxx xxxxxxx č. 325/2011 Xx. xxxxx xxxxxxxxx xxxx 24.11.2011.
Xx xxx xxxxxxxx xxxxxx xxxxxxx xxxxx měněn či xxxxxxxxx.
Xxxxx xxxxxxxxxxxx právních xxxxx xxxxxx právních xxxxxxxx x odkazech xxxx xxxxxxxxxxxxx, xxxxx se xxxx netýká derogační xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.